High-dose of readily available blood thinner reduces risk of death for moderately ill COVID-19 patients
A high dose of an inexpensive and globally available blood-thinning medication reduces the risk of death in hospitalized patients who are moderately ill with COVID-19, suggests a new study led by St. Michael’s Hospital.